AIM ImmunoTech Inc. (AIM)
Trading
Quantity
Profitability
Ownership
Largest Insider Buys in Sector
AIM Insider Trading Activity
AIM Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $247,451 | 19 | 95 |
Sells | $884 | 1 | 5 |
Related Transactions
| Equels Thomas K | CEO & President | 13 | $159,278 | 0 | $0 | $159,278 |
| APPELROUTH STEWART | director | 3 | $48,173 | 0 | $0 | $48,173 |
| Rodino Peter W III | COO, Secretary, Gen. Counsel | 2 | $25,000 | 0 | $0 | $25,000 |
| BRYAN NANCY | director | 1 | $15,000 | 0 | $0 | $15,000 |
| MITCHELL WILLIAM M | director | 0 | $0 | 1 | $884 | $-884 |
About AIM ImmunoTech Inc.
AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome (CFS). It is also developing Ampligen for the treatment of renal cell carcinoma, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, prostate and pancreatic cancer, myalgic …
Insider Activity of AIM ImmunoTech Inc.
Over the last 12 months, insiders at AIM ImmunoTech Inc. have bought $247,451 and sold $884 worth of AIM ImmunoTech Inc. stock.
On average, over the past 5 years, insiders at AIM ImmunoTech Inc. have bought $110,591 and sold $884 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Equels Thomas K (CEO & President) — $159,278. APPELROUTH STEWART (director) — $48,173. Rodino Peter W III (COO, Secretary, Gen. Counsel) — $25,000.
The last purchase of 50,000 shares for transaction amount of $6,730 was made by Equels Thomas K (CEO & President) on 2025‑03‑05.
List of Insider Buy and Sell Transactions, AIM ImmunoTech Inc.
| 2025-03-05 | Equels Thomas K | CEO & President | 50,000 0.0738% | $0.13 | $6,730 | -6.20% | ||
| 2025-03-04 | Equels Thomas K | CEO & President | 127,334 0.1794% | $0.12 | $15,060 | +2.11% | ||
| 2025-03-04 | Equels Thomas K | CEO & President | 44,000 0.0603% | $0.12 | $5,060 | +2.11% | ||
| 2025-03-04 | Equels Thomas K | CEO & President | 83,334 0.1178% | $0.12 | $10,000 | +2.11% | ||
| 2024-12-19 | Sale | MITCHELL WILLIAM M | director | 4,580 0.0071% | $0.19 | $884 | -2.88% | |
| 2024-12-18 | Equels Thomas K | CEO & President | 22,727 0.035% | $0.21 | $4,682 | -4.80% | ||
| 2024-12-02 | APPELROUTH STEWART | director | 11,112 0.0168% | $0.21 | $2,356 | -9.91% | ||
| 2024-11-21 | Equels Thomas K | CEO & President | 20,000 0.0331% | $0.21 | $4,240 | -6.19% | ||
| 2024-11-20 | Equels Thomas K | CEO & President | 145,110 0.2237% | $0.19 | $27,915 | -0.40% | ||
| 2024-11-20 | Equels Thomas K | CEO & President | 85,000 0.1355% | $0.20 | $16,915 | -0.40% | ||
| 2024-11-20 | Equels Thomas K | CEO & President | 60,110 0.0881% | $0.18 | $11,000 | -0.40% | ||
| 2024-11-20 | APPELROUTH STEWART | director | 81,953 0.1267% | $0.19 | $15,817 | -0.40% | ||
| 2024-09-16 | Equels Thomas K | CEO & President | 5,000 0.0089% | $0.30 | $1,515 | -27.76% | ||
| 2024-09-13 | Equels Thomas K | CEO & President | 20,000 0.0363% | $0.31 | $6,160 | -27.59% | ||
| 2024-05-06 | Equels Thomas K | CEO & President | 61,729 0.117% | $0.41 | $25,000 | -37.26% | ||
| 2024-05-06 | Rodino Peter W III | COO, Secretary, Gen. Counsel | 30,865 0.0585% | $0.41 | $12,500 | -37.26% | ||
| 2024-03-21 | BRYAN NANCY | director | 38,462 0.0806% | $0.39 | $15,000 | -27.32% | ||
| 2024-03-15 | Equels Thomas K | CEO & President | 75,758 0.1551% | $0.33 | $25,000 | -13.58% | ||
| 2024-03-15 | APPELROUTH STEWART | director | 90,910 0.1861% | $0.33 | $30,000 | -13.58% | ||
| 2024-03-15 | Rodino Peter W III | COO, Secretary, Gen. Counsel | 37,879 0.0776% | $0.33 | $12,500 | -13.58% |
Insider Historical Profitability
| Equels Thomas K | CEO & President | 1858029 2.7024% | $222,963.48 | 49 | 0 | <0.0001% |
| APPELROUTH STEWART | director | 355509 0.5171% | $42,661.08 | 10 | 0 | <0.0001% |
| Rodino Peter W III | COO, Secretary, Gen. Counsel | 212583 0.3092% | $25,509.96 | 5 | 0 | +7.94% |
| MITCHELL WILLIAM M | director | 118549 0.1724% | $14,225.88 | 2 | 1 | |
| BRYAN NANCY | director | 38462 0.0559% | $4,615.44 | 1 | 0 |
Historical Insider Profitability vs. Competitors
$8,253,997 | 122 | -53.40% | $10.96M | |
$1,724,269 | 63 | -16.36% | $11.21M | |
AIM ImmunoTech Inc. (AIM) | $1,159,104 | 40 | -21.75% | $8.25M |
$95,303,339 | 30 | -13.78% | $11.33M | |
$523,320 | 24 | 94.37% | $7.39M |
AIM Institutional Investors: Active Positions
| Increased Positions | 11 | +28.95% | 169,051 | +1.88% |
| Decreased Positions | 10 | -26.32% | 5M | -50.31% |
| New Positions | 6 | New | 133,625 | New |
| Sold Out Positions | 4 | Sold Out | 4M | Sold Out |
| Total Postitions | 39 | +2.63% | 5M | -48.43% |
AIM Ownership Change vs Market
Institutional Investor Ownership
| Vanguard Group Inc | $268.00 | 2.88% | 1.99M | 0 | 0% | 2024-12-31 |
| Blackrock, Inc. | $94.00 | 1.01% | 698,267 | 0 | 0% | 2024-12-31 |
| Geode Capital Management, Llc | $63.00 | 0.67% | 464,016 | 0 | 0% | 2024-12-31 |
| Citadel Advisors Llc | $48.00 | 0.52% | 358,987 | -98,780 | -21.58% | 2024-12-31 |
| Renaissance Technologies Llc | $35.00 | 0.38% | 260,479 | +17,271 | +7.1% | 2024-12-31 |
| State Street Corp | $23.00 | 0.25% | 173,103 | 0 | 0% | 2024-12-31 |
| Verition Fund Management Llc | $23.00 | 0.25% | 171,000 | +18,000 | +11.77% | 2024-12-31 |
| Northern Trust Corp | $11.00 | 0.12% | 85,119 | 0 | 0% | 2024-12-31 |
| Morgan Stanley | $10.00 | 0.11% | 76,320 | -8,000 | -9.49% | 2024-12-31 |
| Two Sigma Securities, Llc | $10.00 | 0.1% | 71,305 | +71,305 | New | 2024-12-31 |